BMS Archive

Fungi · Scientific monograph

Auricularia auricula-judae

Jelly Ear / Wood Ear

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Coagulation Research, Glucose & Metabolic Research, Immunological Research

Research overview

Historical use

Used in Traditional Chinese Medicine for over 1,000 years, known as 'Mu Er' (wood ear) or 'Hei Mu Er' (black wood ear). Traditionally used for improving blood circulation, treating throat conditions, and as a yin tonic for the lungs and stomach. A common food ingredient in Asian cuisine (soups, stir-fries). Reference to its use for blood disorders found in Ben Cao Gang Mu (Li Shizhen, 1596).

Modern research context

Clinically relevant for its significant anticoagulant and antiplatelet effects — in vitro screening has confirmed potent platelet inhibition by Auricularia extracts [1]. Antidiabetic effects via alpha-glucosidase inhibition and anti-proliferative activity against cancer cell lines are documented in preclinical research [2][4]. Polysaccharide-rich preparations have been evaluated in polyherbal combination formulas for immune support [3]. Immunomodulatory polysaccharides (AAP) exhibit multiple bioactivities in preclinical models [5]. Caution is warranted when consumed in large quantities alongside anticoagulant medication due to additive platelet inhibition [1].

Adverse effects

Significant anticoagulant/antiplatelet effect — risk of bleeding, especially with concurrent anticoagulant use. GI upset with large quantities. Rare hypersensitivity.

Contraindications

Concurrent use with anticoagulants or antiplatelets (warfarin, aspirin, clopidogrel, heparin) — clinically significant bleeding risk. Pre-surgical period — discontinue at least 2 weeks before surgery. Haemophilia or bleeding disorders.

Clinical and phytochemical data

Used part

Fruiting body

Primary active compounds

  • Auricularia auricula polysaccharides (AAP — beta-glucans, acidic heteropolysaccharides)

  • Adenosine (platelet aggregation inhibitor)

  • Ergosterol

  • Lectins

  • Cerebrosides

Mechanism of action

Adenosine and AAP inhibit platelet aggregation via adenosine A2A receptor activation, increasing platelet cAMP and reducing thromboxane A2. Anticoagulant polysaccharides inhibit thrombin and factor Xa (heparin-like mechanism). Hypoglycaemic activity via α-glucosidase inhibition and GLUT4 upregulation in skeletal muscle. Immunomodulation via TLR-4/Dectin-1.

Pharmacokinetics

Absorption

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Oral absorption of ME-2, a homogeneous polysaccharide from Auricularia auricula-judae, was systematically investigated using a dual-labeling pharmacokinetic approach; the study quantified absorption characteristics and intestinal uptake kinetics [1]. Adenosine rapidly absorbed and metabolised. Polysaccharide fractions limited systemic absorption; active at mucosal level. Human PK data for whole extract not available.

Distribution

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Tissue distribution of the Auricularia polysaccharide ME-2 was characterised following oral administration using the same dual-labeling PK study [1], revealing organ-specific accumulation patterns. Adenosine distributes rapidly to red blood cells and vascular endothelium via active transport; plasma half-life ~10 seconds. High-MW anticoagulant polysaccharides distribute to vascular endothelium. Ergosterol distributes to lipid-rich membranes. No formal human PK studies for the fungal extract as a whole.

Metabolism

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Adenosine rapidly deaminated by adenosine deaminase to inosine. Polysaccharides fermented by gut microbiota.

Excretion

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Renal excretion of adenosine metabolites; fecal for polysaccharides.

Safety and interactions

Drug interactions

Lack of clinical studies prevents interaction grading. Unknown safety profile with concomitant drug use.

Toxicity

Well tolerated at dietary amounts based on extensive culinary use. At pharmacological concentrations, the antiplatelet effect is the primary clinical concern; caution is warranted with concurrent anticoagulant therapy. No significant organ toxicity has been identified in animal studies.

Special precautions

Pregnancy

Anticoagulant properties raise concern for increased bleeding risk during pregnancy, particularly peripartum. Avoid concentrated preparations; dietary quantities with medical supervision.

Lactation

No data on breast milk excretion. Dietary use likely safe; concentrated preparations — insufficient data.

Hepatic impairment

No hepatotoxicity documented. If hepatic coagulopathy is present, additive bleeding risk from antiplatelet effect — use with caution.

Renal impairment

No specific risk identified. Adenosine metabolism may be affected in severe renal impairment; monitor.

Sources and references

  1. [1] - Poniedziałek B., "The Effect of Mushroom Extracts on Human Platelet and Blood Coagulation: In vitro Screening of Eight Edible Species.", Nutrients, 2019, PMID: 31842490
  2. [2] - Wong JH., "Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials.", Appl Microbiol Biotechnol, 2020, PMID: 32274562
  3. [3] - Nakyam T., "The Polyherbal Functional Ingredient Containing Ginger, Chinese Date, and Wood Ear Mushroom (Auricularia auricula-judae) Promotes Immune System Activity.", Biomed Res Int, 2023, PMID: 37564141
  4. [4] - Panthong S., "Antioxidant activity, anti-proliferative activity, and amino acid profiles of ethanolic extracts of edible mushrooms.", Genet Mol Res, 2016, PMID: 27813595
  5. [5] - Łysakowska P., "Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production-A Review.", Molecules, 2023, PMID: 37513265

Additional source links

Continue browsing